01592nam a2200325 a 4500001001200000003000800012006001900020007001500039008004100054010001700095020004300112020002700155040002100182035002100203050002700224082002000251100002500271245010700296260004700403300002400450504005100474505033500525533015200860650004101012650002401053655002901077710001701106856012601123999001701249ebr10740178CaPaEBRm     o  u        cr cn|||||||||130222s2013    enkad   sb    001 0 eng d  z  2013006115  z9781409448273 (hardcover : alk. paper)  z9781409448280 (e-book)  aCaPaEBRcCaPaEBR  a(OCoLC)85502284814aHD9665.5b.A574 2013eb04a338.4/761512231 aAnsell, John,d1947-10aTransforming big pharmah[electronic resource] :bassessing the strategic alternatives /cJohn Ansell.  aFarnham, Surrey :bGower Pub. Ltd.,c2013.  axvi, 265 p. :bill.  aIncludes bibliographical references and index.0 apt. I. How pharma differs and why this is important -- pt. II. Assessing management concepts for the pharmaceutical industry -- pt. III. Big pharma's strategic options -- pt. IV. Where will new products come from? -- pt. V. Prospects for new products -- pt. VI. Getting a true fix on prospects -- pt. VII. Conclusions and summary.  aElectronic reproduction.bPalo Alto, Calif. :cebrary,d2013.nAvailable via World Wide Web.nAccess may be limited to ebrary affiliated libraries. 0aPharmaceutical industryxManagement. 0aStrategic planning. 7aElectronic books.2local2 aebrary, Inc.40uhttp://site.ebrary.com/lib/rucke/Doc?id=10740178zAn electronic book accessible through the World Wide Web; click to view  c35299d35299